O'Connor Padraig Andrew forfeited 567 Boston Scientific shares at $48.37 per share after exercising Options for 1,171 shares and 1,171 derivative securities on September 2, 2026. The records show 7,892 shares and 3,516 derivative securities afterward, giving investors a precise view of the reported ownership changes.
Key Highlights
- O'Connor Padraig Andrew is identified as Boston Scientific’s EVP, Global Operations.
- His recorded share ownership reached 8,459 after the option exercise.
- The transaction left him with 3,516 derivative securities.
The transaction included an option exercise for 1,171 shares and a separate exercise involving 1,171 derivative securities.
$48.37 Share Forfeiture Changes Recorded Holdings
Andrew is identified as Boston Scientific’s EVP, Global Operations. The option exercise initially left him with 8,459 shares before the subsequent forfeiture reduced the recorded balance to 7,892 shares. A separate entry records the exercise of 1,171 derivative securities and ownership of 3,516 derivative securities afterward. The option and derivative-security exercises carry transaction code M, while the forfeiture carries code F. All three transactions were dated September 2, 2026.
FAQs
Q: What did O'Connor Padraig Andrew do in the Boston Scientific insider transaction?
A: He exercised options for 1,171 shares and separately exercised 1,171 derivative securities on September 2, 2026. The record also shows a 567-share forfeiture at $48.37 per share.
Q: How did the transaction change O'Connor Padraig Andrew’s Boston Scientific holdings?
A: The transaction record shows 8,459 shares after the option exercise and 7,892 shares after the forfeiture. It also lists 3,516 derivative securities.
Q: What is O'Connor Padraig Andrew’s role at Boston Scientific?
A: O'Connor Padraig Andrew is identified as Boston Scientific’s EVP, Global Operations. The entries identify the exercises with transaction code M and the forfeiture with code F.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.